GlaxoSmithKline (United Kingdom)
In research, GlaxoSmithKline (United Kingdom) stands highest in Health Sciences (#8,114 of 11,982 worldwide) and Medicine (#8,333 of 10,443 worldwide), 2022–2025.
- World rank, 2022–2025
- #6,861 of 28,054 · #1,448 all time
- Rank in United Kingdom
- #271 of 1,094
- Research works
- 5k ▼ 29% vs 2013–17
- Citations
- 263k 52.8 per fractional work
- Top-10% rate
- 18.0% record average 16.5%
- Open access
- 35% world 28%
What is GlaxoSmithKline (United Kingdom) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #8,114 of 11,982 | 14.8% | 85 | #1145 | |
| MedicineField | #8,333 of 10,443 | 13.6% | 77 | #970 |
Each strip is that field’s whole ranked pool, with the notch where GlaxoSmithKline (United Kingdom) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.5×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 8.5×
- Chemistry 6.4×
- Immunology and Microbiology 5.2×
- Veterinary 3.9×
- Biochemistry, Genetics and Molecular Biology 3.1×
- Dentistry 3.0×
- Mathematics 2.1×
- Medicine 2.0×
- Chemical Engineering 1.5×
- Nursing 1.1×
- Decision Sciences 0.8×
- Economics, Econometrics and Finance 0.8×
- Materials Science 0.7×
- Neuroscience 0.7×
- Health Professions 0.6×
- Engineering 0.4×
- Environmental Science 0.3×
- Computer Science 0.3×
- Psychology 0.3×
- Agricultural and Biological Sciences 0.2×
- Arts and Humanities 0.1×
- Energy 0.1×
- Physics and Astronomy 0.1×
- Earth and Planetary Sciences 0.1×
- Social Sciences 0.1×
- Business, Management and Accounting 0.0×
Who are the top researchers at GlaxoSmithKline (United Kingdom)?
Ranked on the composite score, David A. Hall, Vincenzo Libri and Richard P. Marshall lead among researchers whose main affiliation is GlaxoSmithKline (United Kingdom).
- 1 David A. Hall United Kingdom · #152,425 worldwide 144 citations · 22 works
- 2 Vincenzo Libri United Kingdom · #213,441 worldwide 222 citations · 19 works
- 3 Richard P. Marshall United Kingdom · #221,285 worldwide 176 citations · 19 works
- 4 Jim J. Hagan United Kingdom · #269,355 worldwide 143 citations · 19 works
- 5 David Howlett United Kingdom · #287,978 worldwide 101 citations · 39 works
- 6 Joseph P. Adams United Kingdom · #330,210 worldwide 115 citations · 22 works
- 7 Sara Brett United Kingdom · #373,279 worldwide 46 citations · 20 works
- 8 John Riley United Kingdom · #408,888 worldwide 71 citations · 19 works
- 9 Marcus Bantscheff United Kingdom · #421,199 worldwide 70 citations · 15 works
- 10 Neil Upton United Kingdom · #434,534 worldwide 82 citations · 15 works
Which keywords describe research at GlaxoSmithKline (United Kingdom)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Medicinal Chemistry, Diagnosis, Global Burden, Respiratory, Management, COPD and spirometry.
- Staging System
- International Myeloma Working Group
- BET Bromodomains
- Molecular Docking
- Minimal Residual Disease
- Immunogenicity
- Allergic Diseases
- Proteasome Inhibitors
- Pharmacokinetics
- Immunology
- Transcriptional Regulation
- Therapeutic Antibodies
- Clinical Trials
- Biomarkers
- Glycosylation
- spirometry
- Respiratory
- Global Burden
- Medicinal Chemistry
- Inflammation
- Epidemiology
- Diagnosis
- Management
- Treatment
- COPD
- Monoclonal Antibodies
- Antiretroviral Therapy
- Genetics
- Immune Response
- Organic Synthesis
- Drug Discovery
- Drug Resistance
- Asthma
- Transition Metal Catalysis
- Eosinophils
- Biopharmaceuticals
- Cell Culture
- Heterocycles
- Diagnosis Criteria
- PROTACs
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology19▲ 2.4×56 topics
- Inflammation11▲ 2.6×37 topics
- Diagnosis10▲ 5.3×17 topics
- Medicinal Chemistry9▲ 16×7 topics
- Management8▲ 5.4×11 topics
- Global Burden8▲ 7.8×10 topics
- Treatment8▲ 3.2×19 topics
- Respiratory7▲ 37×2 topics
- COPD6▲ 50×1 topic
- spirometry6▲ 50×1 topic
- Monoclonal Antibodies6▲ 32×3 topics
- Glycosylation5▲ 24×3 topics
- Antiretroviral Therapy5▲ 16×6 topics
- Biomarkers5▲ 3.7×12 topics
- Genetics5▲ 3.6×9 topics
- Clinical Trials5▲ 3.6×14 topics
- Immune Response5▲ 4.3×12 topics
- Therapeutic Antibodies4▲ 33×2 topics
- Organic Synthesis4▲ 20×3 topics
- Transcriptional Regulation4▲ 14×6 topics
- Drug Discovery4▲ 9.8×5 topics
- Immunology4▲ 20×2 topics
- Drug Resistance4▲ 7.3×7 topics
- Pharmacokinetics4▲ 7.6×3 topics
- Asthma4▲ 20×3 topics
- Proteasome Inhibitors4▲ 27×2 topics
- Transition Metal Catalysis4▲ 23×4 topics
- Allergic Diseases4▲ 32×1 topic
- Eosinophils4▲ 32×1 topic
- Immunogenicity4▲ 42×3 topics
- Biopharmaceuticals4▲ 34×2 topics
- Minimal Residual Disease4▲ 26×2 topics
- Cell Culture3▲ 15×2 topics
- Molecular Docking3▲ 13×2 topics
- Heterocycles3▲ 18×3 topics
- BET Bromodomains3▲ 56×1 topic
- Diagnosis Criteria3▲ 44×1 topic
- International Myeloma Working Group3▲ 44×1 topic
- PROTACs3▲ 56×1 topic
- Staging System3▲ 26×2 topics
Which research topics does GlaxoSmithKline (United Kingdom) publish most on?
By volume in 2022–2025: Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Multiple Myeloma Research and Treatments and Protein Degradation and Inhibitors.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 6 works
- 2 Asthma and respiratory diseases Physiology 4 works
- 3 Multiple Myeloma Research and Treatments Hematology 3 works
- 4 Protein Degradation and Inhibitors Molecular Biology 3 works
- 5 Computational Drug Discovery Methods Computational Theory and Mathematics 3 works
- 6 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 3 works
- 7 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 3 works
- 8 Catalytic C–H Functionalization Methods Organic Chemistry 2 works
- 9 Protein purification and stability Molecular Biology 2 works
- 10 Statistical Methods in Clinical Trials Statistics and Probability 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has GlaxoSmithKline (United Kingdom)'s research output changed?
Output in 2018–2022 was 29% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in London
- University College London
- Imperial College London
- King's College London
- Queen Mary University of London
- London School of Economics and Political Science
- University of London
- Brunel University of London
- London School of Hygiene & Tropical Medicine
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.